Business Context and Reporting Period
Company: Business First Bancshares, Inc. (Parent of b1BANK)
Filing Type: Form 8-K (Current Report)
Date of Report: October 26, 2023
Reporting Period: Quarter ended September 30, 2023
This filing announces the release of financial results for the third quarter of 2023 and the declaration of dividends for both preferred and common shareholders.
Key Financial Metrics and Dividend Declarations
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the referenced press release (Exhibit 99.1) and investor presentation (Exhibit 99.2), which are not included in the provided text.
Dividend Declarations:
- Preferred Dividend: $18.75 per share (Full quarterly dividend of 1.875% based on a 7.50% annual rate).
- Common Dividend: $0.14 per share.
- Record Date: November 15, 2023.
- Payment Date: November 30, 2023 (or as soon thereafter as practicable).
Material Changes
The filing does not contain specific data to compare current period performance against the prior comparable period. Material changes in financial condition or operations are detailed in the attached exhibits (99.1 and 99.2).
Guidance, Outlook, and Risks
Management Commentary: The Board of Directors has declared dividends, indicating confidence in the company's capital position as of the declaration date.
Regulatory Disclosure: Supplemental information regarding the results was made available under Regulation FD (Item 7.01).
Risks and Contingencies: No specific risks or contingencies are detailed in the text of this 8-K filing.
Investor Verification Checklist
- Verify the specific revenue, net income, and earnings per share figures in the Q3 2023 Press Release (Exhibit 99.1).
- Review the Investor Presentation (Exhibit 99.2) for details on asset quality, liquidity ratios, and non-performing assets.
- Confirm the impact of the declared dividends on the company's retained earnings and capital adequacy ratios.
- Check for any forward-looking guidance or outlook provided in the supplemental materials not included in this summary.